May 31, 2018
Reston, VA – The Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2018 Annual Meeting—the premier educational, scientific and networking event for the nuclear medicine and molecular imaging community—will be held at the Pennsylvania Convention Center in Philadelphia, PA, June 23–26. It will bring together physicians, technologists, pharmacists and scientists from around the globe to share research, network, and collaborate on “Imaging the Future of Human Health.”
The focus is on science—improving patients’ lives by developing new methods to diagnose earlier and more accurately, delivering the most effective therapy for a specific patient’s disease, and monitoring and adjusting treatment to ensure optimum results. Sessions for scientists, physicians, and technologists will cover the latest advances in the field, including the growing role of nuclear medicine and molecular imaging in precision medicine.
A new Saturday evening Opening Ceremony will provide an overview of the meeting and be followed by the Welcome Reception/Exhibit Hall Opening. China is this year’s highlight country, and the president of the Chinese Society of Nuclear Medicine will speak at the Opening Ceremony. The Chinese society will also showcase Chinese culture at the reception and has organized scientific and CE sessions throughout the meeting.
The opening plenary session on Sunday, June 24, will feature the Henry N. Wagner, MD, Lecture on Quantitative Nuclear Imaging: Is SUV the Best We Can Do? given by Richard E. Carson, PhD, professor of radiology, biomedical imaging and biomedical engineering at Yale University; director of the Yale PET Center; and director of graduate studies for Yale’s biomedical engineering program. His presentation will cover tracer kinetic analysis methods used for quantitative brain imaging applications, with a focus on synaptic density imaging, why SUV works as well as it does for FDG oncology studies, and imaging challenges faced in non-brain dynamic studies.
The opening plenary will also include an update on SNMMI’s Value Initiative, presented by 2018-19 SNMMI President Satoshi Minoshima, MD, PhD, professor of radiology and chairman of the Department of Radiology and Imaging Sciences at the University of Utah, Salt Lake City, Utah.
At the Monday, June 25, plenary session, Sanjiv (Sam) Gambhir, MD, PhD, will present the Cassen Lectureship on Multimodality Molecular Imaging of Cell/Gene Therapies for Early Disease Detection and Management. Gambhir is the Virginia and D.K. Ludwig Professor of Cancer Research and the chair of the Department of Radiology at the Stanford University School of Medicine. He also heads up the Canary Center at Stanford for Cancer Early Detection and directs the Molecular Imaging Program at Stanford (MIPS).
New at the meeting this year are “Nuts and Bolts” sessions in each track that will cover a wide variety of subspecialty areas, providing practical information to apply in the clinic. An Interactive Training Showcase in the Exhibit Hall will feature 30-minute training sessions on the use of new technologies and equipment by major exhibitors.
The meeting will have 850 scientific oral presentations and nearly 1,000 posters on cutting-edge research advances. They will cover new tracers and applications as well as emerging technologies. The meeting includes fluciclovine live reader training, updates on appropriate use criteria and coding and reimbursement, and Mo-99 production and availability. In addition, the University of Pennsylvania is organizing the popular Case Review sessions and will present 50 cases.
In nuclear medicine and molecular imaging, the focus is always on the patient, and Patient Education Day, June 24, is an important part of the annual meeting. This year, it will include break-out sessions focusing on neuroendocrine tumors, prostate cancer and lymphoma.
With many concurrent sessions, it’s not possible to attend everything of interest in person. The Virtual Poster Hall and Virtual Meeting will be available after the meeting for further education.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging, a vital element of today’s medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.
SNMMI’s more than 16,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.